|
CeptazDrug - Ceptaz The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Ceftazidime (arginine Formulation)
Strength -
2GM/VIAL
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
050646
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 27, 1990
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Glaxosmithkline
Ceptaz
Tazicef 500mg/vial Injectable; Injection
Tazicef 6gm/vial Injectable; Injection Tazidime 1gm/vial Injectable; Injection Tazidime 2gm/vial Injectable; Injection Tazidime In Plastic Container 1gm/vial Injectable; Injection Tazidime In Plastic Container 2gm/vial Injectable; Injection Ceptaz 10gm/vial Injectable; Injection Ceptaz 1gm/vial Injectable; Injection Ceptaz 2gm/vial Injectable; Injection Tazicef 2gm/vial Injectable; Injection NewDrugInformation |